N.U.A.G.E.S: a survey of nebulisation practice in France with regard to ERS guidelines

M de Monte; J Scruignec; J C Dubus; J P Chaumuzeau; B Dautzenberg; J F Dessanges; M H Becquemin; P Diot; GAT

doi:10.1016/j.rmed.2007.03.004

N.U.A.G.E.S: a survey of nebulisation practice in France with regard to ERS guidelines

Respir Med. 2007 Dec;101(12):2561-5. doi: 10.1016/j.rmed.2007.03.004. Epub 2007 Sep 14.

Authors

M de Monte¹, J Scruignec, J C Dubus, J P Chaumuzeau, B Dautzenberg, J F Dessanges, M H Becquemin, P Diot; GAT

Affiliation

¹ INSERM U618, IFR135, Université François Rabelais de Tours, France.

PMID: 17869081
DOI: 10.1016/j.rmed.2007.03.004

Abstract

A survey of nebulisation practice in France was conducted under the aegis of the French respiratory society in 2004.

Methods: Analysis of a questionnaire was obtained from 3674 physicians.

Results: A total of 2439 physicians were general practitioners (GPs), 698 were chest physicians, and 537 paediatricians. The main reasons to use nebulisation are (1) for chest physicians efficacy in treating various pathologies with long-term administration (1 wk to 1 month) of approved drugs, and (2) for GP's local action properties. While chest physicians learned about nebulisation during their university training and do not ask for additional information, GPs learned by practical experience or from colleagues and ask for further information.

Conclusion: This study will help to develop targeted educational programmes on nebulisation practice.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Administration, Inhalation
Bronchodilator Agents / administration & dosage*
Bronchodilator Agents / therapeutic use
Education, Medical, Continuing / methods
Family Practice / education
France
Humans
Nebulizers and Vaporizers*
Pediatrics / education
Practice Patterns, Physicians'
Pulmonary Disease, Chronic Obstructive / drug therapy*
Pulmonary Medicine / education
Surveys and Questionnaires

Substances

Bronchodilator Agents